SLOTPLAYERSTATUSSTARTS THROUGH W5WEEK 7 PTSPOINTS WHILE ROSTERED THROUGH W5
FLEXJaylen WarrenRB • PIT—522.5114.0
RBChristian McCaffreyRB • SF—521.7102.4
RBJavonte WilliamsRB • DAL—528.0102.4
TEIsaiah LikelyTE • NYG—54.287.4
BenchJuwan JohnsonTE • NO—10.764.3
WRJameson WilliamsWR • DET—527.160.6
FLEXJalen CokerWR • CAR—20.958.2
BenchDJ MooreWR • BUF—50.044.0
BenchDevaughn VeleWR • NO—015.440.3
BenchBrenton StrangeTE • ——10.014.8
WRA.J. BrownWR • NE—16.84.6
BenchJosh JacobsRB • GB—020.20.0
BenchTyreek HillWR • ——00.00.0
D/ST49ers D/STD/ST • ———-2.0—
QBC.J. StroudQB • ———14.7—
KChris BoswellK • ———12.0—
LATEST RESULT
L 135.92–164.04 vs Pollard Greens
WEEK 5 COVERAGE
Kupp posted a league-high 177.60 against Royrek’s 136.86 and moves to 4–1. Jaylen Warren, Isaiah Likely and Brenton Strange combined for 96.5; DJ Moore’s zero was rendered administrative.
UNAUTHORIZED BIOGRAPHY
Compiled from league records, disputed testimony and messages presented without context.
PERSONNEL 01
Roy Bird
Keeper of the Strategic Reserve
KNOWN AS: Roy • Roy Bird
Roy operates one of the league’s more traditional franchises: recognizable players, a compliant team name and enough unused bench production to survive an unexpected audit. His decision to preserve Jalen Coker’s 37.8 points during a Week 1 victory has been described internally as strategic inventory management.
CURRENT INSTITUTIONAL POSTURE5-2 • 2 in the table • Week 7 complete
INSTITUTIONAL TENDENCIES
01Preserves emergency bench points
02Maintains naming compliance
03Avoids unnecessary panic
CAREER INCIDENTS
Week 1 — Won with Coker’s 37.8 on the bench.
Week 2 — Won 100.48–95.48.
Week 3 — Lost 137.90–113.44 to Route 22.
SEASON / LEADING RETURNS
01Jaylen Warren — 114.0
02Christian McCaffrey — 102.4
03Javonte Williams — 102.4
RECENT TRANSACTIONS
2026-09-16Waiver claimAdded 49ers D/ST • $2
2026-09-16Waiver claimAdded Devaughn Vele • $12
FRANCHISE MYTHOLOGY
FILE 01
Roy Bird
the name used by the institution.
FILE 02
The Coker Reserve
37.8 points preserved on the bench during a victory.
RECENT COVERAGE
No dedicated coverage yet. This should not be interpreted as institutional approval.
Brief